AnalyzeDirect Shevtsov MA, Nikolaev BP, Yakovleva LY, Dobrodumov AV, Zhakhov AV, Mikhrina AL, Pitkin E, Parr MA, Rolich VI, Simbircev AS, Ischenko AM. Recombinant interleukin-1 receptor antagonist conjugated to superparamagnetic iron oxide nanoparticles for theranostic targeting of experimental glioblastoma. Neoplasia. January 2015;17(1):32-42.
Full Text – Open Access
Publication Date
January 2015
How Analyze was Used
“For an estimation of the accumulation of nanoparticles in the tumor, we used MSME MR sequences. The obtained images were analyzed using Analyze software (AnalyzeDirect, Inc, Overland Park, KS).”
Keywords
Brain Edema
Contrast Media
Diagnosis
Disease Models, Animal
Glioma
Interleukin 1 Receptor Antagonist Protein
Magnetic Resonance Imaging (MRI)
Magnetite Nanoparticles
Rats
Recombinant Proteins
Treatment Outcome
Author Affiliation(s)
Institute of Cytology of the Russian Academy of Sciences (RAS), St. Petersburg, Russia. (MAS)
A.L. Polenov Russian Research Scientific Institute of Neurosurgery, St. Petersburg, Russia. (MAS)
Research Institute of Highly Pure Biopreparations, St. Petersburg, Russia. (BPN, LYY, AVZ, ASS, AMI)
Institute of Macromolecular Compounds of the Russian Academy of Sciences (RAS), St. Petersburg, Russia. (AVD)
I.M. Sechenov Institute of Evolutionary Physiology and Biochemistry of the Russian Academy of Sciences (RAS), St. Petersburg, Russia. (ALM)
Wharton School, University of Pennsylvania, Philadelphia, PA, US. (EP)
V.F. Fock Institute of Physics, St. Petersburg State University, St. Petersburg, Russia. (MAP, VIR)
ID# 1594
Tags: Animal Disease Models, Brain Edema, Contrast Media, Diagnosis, Glioma, Interleukin 1 Receptor Antagonist Protein, Magnetic Resonance Imaging (MRI), Magnetite Nanoparticles, Rats, Recombinant Proteins, Treatment Outcome